Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (421-430 of 682) with videos related to

Pageof 69
Sort By:
Pharmacotherapy|November 14, 2022
Performance of different body weights in the Cockcroft-Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohortMichaelia D Cucci, Anthony T Gerlach, Caroline Mangira, et al.
Journal of Intensive Care|September 11, 2022
Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patientsLowell Ling, Oliver Oi Yat Mui, Kevin B Laupland, et al.
The International Journal of Artificial Organs|September 10, 2015
Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?Janattul-Ain Jamal, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2019
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous HemodiafiltrationFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 19, 2026
Nimodipine dosing and pharmacokinetic variability in subarachnoid hemorrhage patientsJudith Bellapart, María Patricia Hernández-Mitre, Xiaolin Wu, et al.
International Journal of Antimicrobial Agents|February 14, 2026
Population pharmacokinetics of cefazolin and metronidazole in patients undergoing elective colorectal surgeryRochelle Ryan, Scott McDonald, Steven C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2024
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patientsPhilip R Selby, Aaron J Heffernan, David Yeung, et al.
Microbiology Spectrum|April 20, 2022
Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection ModelMinyon L Avent, Kate L McCarthy, Fekade B Sime, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2020
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrationsNynke G L Jager, Reinier M van Hest, Jiao Xie, et al.
Critical Care (London, England)|April 19, 2015
Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo studyKiran Shekar, Jason A Roberts, Charles I Mcdonald, et al.
Pageof 69

Showing results (421-430 of 682) with videos related to

Sort By:
Pageof 69
Pharmacotherapy|November 14, 2022
Performance of different body weights in the Cockcroft-Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohortMichaelia D Cucci, Anthony T Gerlach, Caroline Mangira, et al.
Journal of Intensive Care|September 11, 2022
Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patientsLowell Ling, Oliver Oi Yat Mui, Kevin B Laupland, et al.
The International Journal of Artificial Organs|September 10, 2015
Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?Janattul-Ain Jamal, Andrew A Udy, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2019
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous HemodiafiltrationFekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 19, 2026
Nimodipine dosing and pharmacokinetic variability in subarachnoid hemorrhage patientsJudith Bellapart, María Patricia Hernández-Mitre, Xiaolin Wu, et al.
International Journal of Antimicrobial Agents|February 14, 2026
Population pharmacokinetics of cefazolin and metronidazole in patients undergoing elective colorectal surgeryRochelle Ryan, Scott McDonald, Steven C Wallis, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2024
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patientsPhilip R Selby, Aaron J Heffernan, David Yeung, et al.
Microbiology Spectrum|April 20, 2022
Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection ModelMinyon L Avent, Kate L McCarthy, Fekade B Sime, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2020
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrationsNynke G L Jager, Reinier M van Hest, Jiao Xie, et al.
Critical Care (London, England)|April 19, 2015
Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo studyKiran Shekar, Jason A Roberts, Charles I Mcdonald, et al.
Pageof 69